March 9, 2015 — Boston Scientific Corp. announced the settlement of the breach of merger agreement lawsuit brought by ...
Biotronik announced the presentation of data from the iliac arm of the BIOFLEX-I clinical trial at the Cardiovascular Research Technologies (CRT) conference in Washington, D.C. The BIOFLEX-I trial is designed to support U.S. Food and Drug Administration (FDA) approval of the Astron self-expanding nitinol stent to treat patients suffering from common iliac or external iliac artery disease.
AliveCor Inc. announced the launch of the latest version of the AliveECG app, which instantly detects when an electrocardiogram (ECG) is either normal or unreadable.
SPONSORED CONTENT — Studycast is a comprehensive imaging workflow system that allows healthcare professionals to work ...
Fujifilm Medical Systems U.S.A. Inc. will demonstrate the latest version of Synapse Cardiovascular 6.0 and Synapse 3-D 4.1 at the American College of Cardiology (ACC) 64th Annual Scientific Session & Expo on March 14 -16 in San Diego, California.
Corindus Vascular Robotics Inc. announced it has initiated a clinical trial of its CorPath System in peripheral vascular interventions. The study is currently enrolling patients at the Medical University of Graz in Graz, Austria, and is led by Prof. Marianne Brodmann, M.D., a leading researcher with the university’s Division of Angiology, in combination with Prof. Hannes Deutschmann, M.D., of the Medical University of Graz Department of Radiology, and study chairman, Ehtisham Mahmud, M.D., director, Sulpizio Cardiovascular Center-Medicine, UC San Diego.
Bracco Imaging, through its business unit Bracco Injeneering SA, announced the availability of its EmpowerCTA+, an advanced engineering contrast injection system.
Providing exceptional cardiovascular care for patients to achieve the best possible outcomes is the number one goal for ...
The American College of Cardiology (ACC) has launched version 2.0 of their Guideline Clinical App. With the addition of the healthy lifestyle and obesity guidelines, the app now contains the full set of clinical prevention guidelines released by ACC/American Heart Association in 2013.
Merck announced results from two post-hoc analyses of the TRA 2°P TIMI 50 (Thrombin Receptor Antagonist in Secondary Prevention of Atherothrombotic Ischemic Events) trial of Zontivity (vorapaxar), one of the largest secondary prevention studies of an antiplatelet medicine.
Mountain States Health Alliance (MSHA) wanted consistency in care and data reporting from all its facilities, and through use of its CVIS it was able to greatly improve workflow, cut reporting time, reduce critical results turnaround times with chest pain patients in the emergency department, and improve quality data reporting standards.
Cardiac positron emission tomography (PET) is growing in popularity among cardiologists because it provides the ability ...
TomTec Imaging Systems GmbH will introduce its 4-D RV-Function software for right ventricular function analysis at the 64th Annual Scientific Session of the American College of Cardiology (ACC. 2015).
A three-year review of data on the Combo Dual Therapy Stent was presented at the Joint Interventional Meeting (JIM) 2015 in Rome. These data demonstrate the healing benefits of the Combo Dual Therapy Stent in the treatment of coronary artery disease in the short, medium and long-term.
Biotronik announced that its ProMRI and ProMRI AFFIRM studies have been published in Heart Rhythm, the official journal of the Heart Rhythm Society, validating the safety testing of Biotronik’s ProMRI technology.
When performing radiofrequency (RF) ablation to treat cardiac arrhythmia, medical professionals must balance the safety ...
The Centers for Medicare and Medicaid Services (CMS) has released the 2015 National Impact Assessment of Quality Measures Report (2015 Impact Report).
A new, online report predicts where American hospitals will spend billions on healthcare technology in 2015, centering on ICD-10 migration and population health management solutions.

As an early adopter of fractional flow reserve (FFR) for the diagnosis of ischemia, my initial decision to transition ...